代谢 了解癌的可变风险因素:一个双样本的门德尔随机化研究
Yihao Zhu1, Ke Wang2, Yuan Yu3
1Department of Urology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Discover oncology
|July 28, 2025
概括
身体质量指数 (BMI) 增加癌风险,但4-氨酸可能提供部分保护. 通过调节蛋白酶活性,SLPI促进与肥胖相关的癌.
科学领域:
- 代谢学和基因组学
- 癌症研究 癌症研究
- 流行病学 流行病学
背景情况:
- 循环中的代谢物与癌的发展有关,但机制尚不清楚.
- 调查代谢物作用和癌的遗传基础至关重要.
研究的目的:
- 阐明血和尿路代谢物在癌中的作用.
- 探索癌发展中的遗传和可修改的风险因素.
主要方法:
- 两个样本的孟德尔随机化 (MR) 检测代谢物-尿代谢物与癌的关联.
- 分析TCGA和GEO数据库的风险因素机制和SLPI的作用.
主要成果:
- 鉴定了六种与癌相关的血和一种尿路代谢物.
- 确定的BMI和1型糖尿病作为危险因素;构建的BMI-代谢物-癌症网络.
- 在肥胖症中,SLPI显著影响癌预后和瘤发生.
结论:
- 体重指数 (BMI) 增加了癌的风险;4 - 瓜因丁诺布他酸可能会减轻这种风险.
- 在肥胖相关的癌中,SLPI通过蛋白酶活性调节促进瘤发生.
相关概念视频
Randomized Experiments
7.2K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
7.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
176
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
176
Renal Drug Clearance: Comparison Between Renal Excretion Methods
277
Renal clearance is a critical parameter encompassing kidney filtration, secretion, and reabsorption processes. It is calculated using a specific equation to determine the rate at which the kidneys clear a drug.
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
Renal clearance is often associated with the renal glomerular filtration rate (GFR), which represents the rate at which plasma is filtered through the glomeruli in the kidney. When drug reabsorption is minimal and there is no active secretion, renal clearance is closely related to the...
277


